Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating atherosclerosis

A technology of atherosclerosis and drugs, applied in the direction of drug combinations, cardiovascular system diseases, etc., can solve problems such as blocking, kidney function damage, and affecting the normal operation of the body

Inactive Publication Date: 2015-01-14
WUXI XINDA MEDICAL DEVICE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Currently used lipid-lowering drugs and anti-platelet drugs mainly have two problems: (1) blocking the function of substances required for normal physiological operations, such as HMG-CoA reductase in oxidatively modified low-density lipoproteins leading to atherosclerosis The human body has important physiological functions, and the use of drugs such as HMG-CoA reductase inhibitors will inhibit the normal physiological functions of this enzyme in the human body
Of course, the use of this drug can reduce the accumulation of lipids to a certain extent, but it will also cause the human body's own HMG-CoA enzyme to lose other physiological functions, and long-term use will affect the normal operation of the body
(2) This type of drug causes great damage to liver and kidney functions, and long-term use will inevitably cause liver and kidney diseases
However, most people are only used to looking at the curative effect, and are unwilling to pay attention to the side effects of drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating atherosclerosis
  • Medicine for treating atherosclerosis
  • Medicine for treating atherosclerosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A medicine for treating atherosclerosis, comprising a therapeutically effective dose of a glucokinase inhibitor and a therapeutically effective dose of pentitol, characterized in that the glucokinase inhibitor is:

[0028]

[0029] Described pentitol is:

[0030]

[0031] The ratio of the above two substances is controlled at 1:1, and the ratio is a molar ratio.

[0032] Experiments have proved that the combined use of the two drugs can effectively treat atherosclerosis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating atherosclerosis. The medicine contains a therapeutically-effective amount of a glucokinase inhibitor and a therapeutically-effective amount of pentitol. The medicine can be used for effectively treating the atherosclerosis.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating atherosclerosis. Background technique [0002] Atherosclerosis (atherosclerosis) is the most common and most important type of vascular disease of arteriosclerosis, which is characterized by the involvement of arterial lesions starting from the intima. Generally, there is accumulation of lipids and complex carbohydrates, hemorrhage and thrombosis, fibrous tissue hyperplasia and calcium deposition, and gradual degeneration and calcification of the arterial media. The lesions often involve elastic and large and medium muscular arteries. Once they develop enough to block Arterial lumen, the tissue or organ supplied by the artery will be ischemic or necrotic. Atherosclerosis is called atherosclerosis because of the yellow ather-like appearance of lipids that build up in the lining of the arteries. [0003] Atherosclerosis is a disease affecting the intima of arteries of the sys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/506A61P9/10
CPCA61K31/506
Inventor 王岳荣
Owner WUXI XINDA MEDICAL DEVICE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products